| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S00428-009-0848-1 |
| P8608 | Fatcat ID | release_ef5duwdug5direyg5znorrqisy |
| P698 | PubMed publication ID | 19921253 |
| P50 | author | Masafumi Abe | Q115415520 |
| Shinichi Kikuchi | Q117309469 | ||
| P2093 | author name string | Michiko Sato | |
| Michiyuki Hakozaki | |||
| Hiroshi Hojo | |||
| Hitoshi Yamada | |||
| Takahiro Tajino | |||
| P2860 | cites work | Cyclooxygenase in biology and disease | Q27863453 |
| Germline and somatic NF1 mutations in sporadic and NF1-associated malignant peripheral nerve sheath tumours | Q28306740 | ||
| Cyclooxygenases 1 and 2 | Q29615645 | ||
| Chromosome 17p deletions and p53 gene mutations associated with the formation of malignant neurofibrosarcomas in von Recklinghausen neurofibromatosis | Q30531015 | ||
| EGFR and cancer prognosis | Q34399312 | ||
| The ErbB receptors and their role in cancer progression. | Q35089324 | ||
| Recurrent chromosomal imbalances and structurally abnormal breakpoints within complex karyotypes of malignant peripheral nerve sheath tumour and malignant triton tumour: a cytogenetic and molecular cytogenetic study. | Q35588092 | ||
| Correlation between clinicopathological features and karyotype in spindle cell sarcomas. A report of 130 cases from the CHAMP study group | Q35787146 | ||
| Multiple roles of COX-2 in tumor angiogenesis: a target for antiangiogenic therapy | Q35793283 | ||
| Tumor suppressor mutations and growth factor signaling in the pathogenesis of NF1-associated peripheral nerve sheath tumors. I. The role of tumor suppressor mutations | Q35973936 | ||
| Cyclooxygenase-2 and epidermal growth factor receptor: pharmacologic targets for chemoprevention | Q36002131 | ||
| Malignant Peripheral Nerve Sheath Tumor: molecular pathogenesis and current management considerations | Q37089105 | ||
| EGFR and erbB2 in malignant peripheral nerve sheath tumors and implications for targeted therapy | Q37284362 | ||
| Celecoxib, a cyclooxygenase-2 inhibitor, induces apoptosis in human osteosarcoma cell line MG-63 via down-regulation of PI3K/Akt | Q40035818 | ||
| Cyclooxygenase-2 promotes cell proliferation, migration and invasion in U2OS human osteosarcoma cells | Q40068408 | ||
| Synergistic effects of meloxicam and conventional cytotoxic drugs in human MG-63 osteosarcoma cells | Q40152228 | ||
| Etodolac, a selective cyclooxygenase-2 inhibitor, induces apoptosis by activating caspases in human malignant rhabdoid tumor cells (FRTK-1). | Q40201365 | ||
| Establishment and characterization of a new cell line, FPS-1, derived from human undifferentiated pleomorphic sarcoma, overexpressing epidermal growth factor receptor and cyclooxygenase-2. | Q40210373 | ||
| Establishment of three malignant peripheral nerve sheath tumor cell lines, FU-SFT8611, 8710 and 9817: conventional and molecular cytogenetic characterization. | Q40211313 | ||
| Establishment and characterization of a new cell line, FRTK-1, derived from human malignant rhabdoid tumor of the kidney, with overexpression of epidermal growth factor receptor and cyclooxygenase-2. | Q40258996 | ||
| Zoledronic acid cooperates with a cyclooxygenase-2 inhibitor and gefitinib in inhibiting breast and prostate cancer. | Q40344869 | ||
| Tumor growth inhibition by simultaneously blocking epidermal growth factor receptor and cyclooxygenase-2 in a xenograft model | Q40376669 | ||
| Aberration of epidermal growth factor receptor expression in bone and soft-tissue tumors: protein overexpression, gene amplification and activation of downstream molecules | Q40535662 | ||
| A selective cyclooxygenase-2 inhibitor, NS-398, inhibits cell growth by cell cycle arrest in a human malignant fibrous histiocytoma cell line. | Q40586106 | ||
| Combination of a selective cyclooxygenase-2 inhibitor with epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 and protein kinase A antisense causes cooperative antitumor and antiangiogenic effect. | Q40657509 | ||
| A new human malignant peripheral nerve sheath tumour-cell line, HS-sch-2, harbouring p53 point mutation | Q40868787 | ||
| Human malignant fibrous histiocytomas in vitro: growth characteristics and their association with expression of mRNA for platelet-derived growth factor, transforming growth factor-alpha and their receptors | Q40968459 | ||
| Characterization and chemosensitivity of two human malignant peripheral nerve sheath tumour cell lines derived from a patient with neurofibromatosis type 1. | Q40989126 | ||
| Molecular characterization of a 17q11.2 translocation in a malignant schwannoma cell line | Q41590695 | ||
| Expression of p53 in human neuroblastoma- and neuroepithelioma-derived cell lines. | Q41644357 | ||
| Detection of aberrations of the p53 alleles and the gene transcript in human tumor cell lines by single-strand conformation polymorphism analysis | Q41675964 | ||
| Establishment of an epithelioid malignant schwannoma cell line (YST-1). | Q41756162 | ||
| Establishment and characterization of a human malignant schwannoma cell line (HKMS) | Q42814298 | ||
| Simultaneously targeting epidermal growth factor receptor tyrosine kinase and cyclooxygenase-2, an efficient approach to inhibition of squamous cell carcinoma of the head and neck | Q45050425 | ||
| Combined targeting of the epidermal growth factor receptor and cyclooxygenase-2 pathways | Q46689384 | ||
| Meloxicam inhibits osteosarcoma growth, invasiveness and metastasis by COX-2-dependent and independent routes | Q46747952 | ||
| Amphiregulin and epidermal growth factor receptor expression in human malignant fibrous histiocytoma of soft tissues | Q47576005 | ||
| Detection of p53 mutations in hematological malignancies: comparison between immunocytochemistry and DNA analysis. | Q53470657 | ||
| Somatic deletion of the neurofibromatosis type 1 gene in a neurofibrosarcoma supports a tumour suppressor gene hypothesis | Q70732482 | ||
| TP53 mutations are frequent in malignant NF1 tumors | Q71648002 | ||
| Alterations at chromosome 17 loci in peripheral nerve sheath tumors | Q72393558 | ||
| The expression of p53 protein in non-Hodgkin's lymphomas is not always dependent on p53 gene mutations | Q72553924 | ||
| Rb and TP53 pathway alterations in sporadic and NF1-related malignant peripheral nerve sheath tumors | Q74020575 | ||
| Epidermal growth factor receptor and insulin-like growth factor-I receptor expression and function in human soft-tissue sarcoma cells | Q74152025 | ||
| Immunohistochemical and molecular analysis of p53, RB, and PTEN in malignant peripheral nerve sheath tumors | Q74315580 | ||
| Epidermal growth factor receptor expression and mutational analysis in synovial sarcomas and malignant peripheral nerve sheath tumors | Q81192256 | ||
| P4510 | describes a project that uses | FMS-1 | Q54835091 |
| P433 | issue | 6 | |
| P921 | main subject | malignant peripheral nerve sheath tumor | Q654485 |
| adult malignant schwannoma | Q18557919 | ||
| cell line | Q21014462 | ||
| P304 | page(s) | 517-526 | |
| P577 | publication date | 2009-11-18 | |
| P1433 | published in | Virchows Archiv | Q19059548 |
| P1476 | title | Establishment and characterization of a novel human malignant peripheral nerve sheath tumor cell line, FMS-1, that overexpresses epidermal growth factor receptor and cyclooxygenase-2. | |
| P478 | volume | 455 |
| Q38775607 | Explant culture of sarcoma patients' tissue |
| Q33739269 | Hypoxia-inducible factor 1 alpha is a poor prognostic factor and potential therapeutic target in malignant peripheral nerve sheath tumor |
| Q34705278 | Imatinib mesylate inhibits cell growth of malignant peripheral nerve sheath tumors in vitro and in vivo through suppression of PDGFR-β. |
| Q33737662 | Malignant Peripheral Nerve Sheath Tumors State of the Science: Leveraging Clinical and Biological Insights into Effective Therapies. |
| Q35091515 | Overexpression of cyclooxygenase-2 in malignant peripheral nerve sheath tumor and selective cyclooxygenase-2 inhibitor-induced apoptosis by activating caspases in human malignant peripheral nerve sheath tumor cells |
| Q90394601 | The Role of Polycomb Repressive Complex in Malignant Peripheral Nerve Sheath Tumor |
| Q33826589 | Trp53 haploinsufficiency modifies EGFR-driven peripheral nerve sheath tumorigenesis |
| Q54835091 | FMS-1 | described by source | P1343 |
Search more.